Effect and mechanism of phytoestrogen α-Zearalanol on NO and ET-1 secretion induced by oxLDL in human umbilical vein endothelial cells

Chinese Pharmacological Bulletin

Volumn 21, Issue 6, 2005, Pages 692-697

  Xu, Hai Shan ^a   Duan, Jin Hong ^a   Sun, Ren Yu ^a   Wang, Xiao Ming ^a   Xu, Xue Mei ^a   Wu, Yun Qing ^a   Cheng, Jin Xuan ^a   Dai, Shun Ling ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Endothelin 1; Nitric oxide; oxLDL; Phytoestrogen

Indexed keywords

ALPHA ZERALANOL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ESTRADIOL; FULVESTRANT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHYTOESTROGEN; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 23444456941     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Kerlikowske K, Miglioretti DL, Ballard-Barbash R et al. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population[J]. J Clin Oncol, 2003, 21(23):4314-21.
2. Cos P, De Bruyne T, Apers S et al. Phytoestrogens: recent developments[J]. Planta Med, 2003, 69(7):589-99.
3. Dai SL, Duan JH, Lu Y et al. A new phytoestrogen α-Zearalanol markedly inhibits the progression of experimental atherogenesis [J]. Chin J Arterioscler, 2003, 11(5):385-90.
4. Galle J, Stunz P, Schollmeyer P, Wanner C. Oxidized LDL and lipoprotein(a) stimulate renin release of juxtaglomerular cells[J]. Kidney Int, 1995, 47:45-52.
5. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria[J]. J Clin Invest, 1973, 52(11):2745 -56.
6. Busconi L, Michel T. Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization [J]. J Biol Chem, 1993, 268(12):8410-3.
7. Zagariya A, Doherty J, Bhat R et al. Elevated immunoreactive endothelin-1 levels in newborn rabbit lunges after meconium aspiration[J]. Pediatr Crit Care Med, 2002, 3(3):297-302.
8. 2+ response between estrogen and phytoestrogen alpha-zearalanol in ventricular myocytes[J]. Endocrine, 2004, 24(1):33-8.
9. Bilsel AS, Moini H, Tetik E et al. 17Beta-estradiol modulates endothelin-1 expression and release in human endothelial cells[J]. Cardiovasc Res, 2000, 46(3):579-84.
10. Hirata K, Miki N, Kuroda Y et al. Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells[J]. Circ Res, 1995, 76(6):958-62.
11. Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase [J]. J Biol Chem, 1995, 270(1):319-24.
12. Enderlein M, Gross P. Additive effects of oxidized low-density lipoproteins and cyclosporine on endothelin-1 production of renal arterial endothelial cells[J]. Transplant Proc, 2003, 35(4):1581-3.
13. Huang A, Kaley G. Gender-specific regulation of cardiovascular function: estrogen as key player[J]. Microcirculation, 2004, 11 (1):9-38.